EGREGORA
ActiveSummary
The computed 12-month bankruptcy probability of EGREGORA is 3.5% (moderate). The 2024 annual accounts show equity of €9.1m and a net result of €5.0m. Equity is growing by about 5% per year across the filed financial years. Its solvency ranks better than 93% of 4,582 sector peers (NACE 70, financial year 2024). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
1 holding · 12 subsidiaries in the treeHoldings 1
-
100%
All subsidiaries, including indirect ones 12
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
NOVASOL 100%11 subsidiaries
- NOVASOL CHEMICALS FRANCE SASFR 100%
- NOVASOL CHEMICALS ITALIA SRLIT 100%
- NOVASOL CHEMICALS KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİTR 100%
- Novasol Chemicals Switzerland GmbHCH 100%
- NOVASOL CHEMICALS UK LtdGB 100%
- Novasol Chemie GmbhDE 100%
- Novasol North America IncCA 100%
- NOVASOL CHEMICALS IBERICAES 78%
- Novasol China LimitedHK 75%
- Novasol Hong Kong LimitedHK 75%
- NOVASOL CHEMICALS SP S.L. (SOCIEDAD UNIPERSONAL)ES consolidated
According to the 2024 annual accounts of EGREGORA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
1 connected companyThe connected companies are in the list below.